Prevalence and determinants of attention deficit/hyperactivity disorder (ADHD) medication use during pregnancy: Results from the Quebec Pregnancy/Children Cohort-Reference-Cited by-同舟云学术

Prevalence and determinants of attention deficit/hyperactivity disorder (ADHD) medication use during pregnancy: Results from the Quebec Pregnancy/Children Cohort

Published:2021-05 Issue:3 Volume:9 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Lemelin Maxim¹²,Boukhris Takoua¹,Zhao Jin‐Ping²,Sheehy Odile²,Bérard Anick¹²^ORCID

Affiliation:

1. Faculty of Pharmacy University of Montreal Montreal Quebec Canada

2. Research Center CHU Sainte‐Justine Montreal Quebec Canada

Funder

Fonds de Recherche du Québec - Santé

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.781

Reference52 articles.

1. Trends in Attention-Deficit/Hyperactivity Disorder Drug Consumption in Children and Adolescents in Slovenia from 2001 to 2012: A Drug Use Study from a National Perspective

2. Updated European Consensus Statement on diagnosis and treatment of adult ADHD

3. ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

4. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology

5. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy of Chronic Neuropsychiatric Conditions During Pregnancy;Nursing for Women's Health;2024-06

2. Impact of COVID-19 pandemic on prescription stimulant use among children and youth: a population-based study;European Child & Adolescent Psychiatry;2024-01-05

3. Trajectories of ADHD medication use before, during, and after pregnancy: A population‐based study from Norway and Sweden;Pharmacoepidemiology and Drug Safety;2023-06-20

4. In utero exposure to ADHD medication and long-term offspring outcomes;Molecular Psychiatry;2023-02-09

5. Obstetric complications in mothers with ADHD;Frontiers in Reproductive Health;2022-11-07